| EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | | chr10:79718939-79719186:- | ENST00000619625.3 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_exonic | MSTB1 | chr10:79718939-79719186:-.alignment |
| chr10:79722462-79725029:- | ENST00000619625.3 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_exonic | MSTB1,MSTA,MLT1D,AluJb,AluSx,AluJo,L1MB4 | chr10:79722462-79725029:-.alignment |
| chr10:79731926-79732970:- | ENST00000596088.4 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | L2c,AluSx4,L2a,AluSz6 | chr10:79731926-79732970:-.alignment |
| chr10:79731926-79732970:- | ENST00000600376.4 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | L2c,AluSx4,L2a,AluSz6 | chr10:79731926-79732970:-.alignment |
| chr10:79731926-79732970:- | ENST00000601369.4 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | L2c,AluSx4,L2a,AluSz6 | chr10:79731926-79732970:-.alignment |
| chr10:79731926-79732970:- | ENST00000619625.3 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | L2c,AluSx4,L2a,AluSz6 | chr10:79731926-79732970:-.alignment |
| chr10:79738639-79739085:- | ENST00000596088.4 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | AluJr4,AluSx1 | chr10:79738639-79739085:-.alignment |
| chr10:79738639-79739085:- | ENST00000600376.4 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | AluJr4,AluSx1 | chr10:79738639-79739085:-.alignment |
| chr10:79738639-79739085:- | ENST00000601369.4 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | AluJr4,AluSx1 | chr10:79738639-79739085:-.alignment |
| chr10:79738639-79739085:- | ENST00000619625.3 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | AluJr4,AluSx1 | chr10:79738639-79739085:-.alignment |
| chr10:79739632-79740454:- | ENST00000596088.4 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | AluJo,AluJb | chr10:79739632-79740454:-.alignment |
| chr10:79739632-79740454:- | ENST00000600376.4 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | AluJo,AluJb | chr10:79739632-79740454:-.alignment |
| chr10:79739632-79740454:- | ENST00000601369.4 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | AluJo,AluJb | chr10:79739632-79740454:-.alignment |
| chr10:79739632-79740454:- | ENST00000619625.3 | ENSG00000225484.5 | NUTM2B-AS1 | ncRNA_intronic | AluJo,AluJb | chr10:79739632-79740454:-.alignment |
| ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
| ENSG00000225484.5,NUTM2B-AS1 | BLCA | EAG | Eosinophils | 2.4548e-02 | 0.4167 |  |
| chr10:79718939-79719186:- | BRCA | EER | NK_cells_activated | 7.2722e-03 | -0.2108 |  |
| chr10:79722462-79725029:- | BRCA | EER | T_cells_regulatory_(Tregs) | 1.0357e-02 | 0.2647 | .chr10_79722462-79725029_-.png) |
| ENSG00000225484.5,NUTM2B-AS1 | BRCA | EAG | NK_cells_activated | 3.5215e-03 | -0.1865 |  |
| ENSG00000225484.5,NUTM2B-AS1 | CESC | EAG | T_cells_regulatory_(Tregs) | 8.8159e-03 | 0.4191 | .ENSG00000225484.5,NUTM2B-AS1.png) |
| ENSG00000225484.5,NUTM2B-AS1 | COAD | EAG | Dendritic_cells_activated | 8.5162e-03 | 0.4960 |  |
| chr10:79718939-79719186:- | ESCA | EER | Eosinophils | 1.1317e-02 | 0.3054 |  |
| chr10:79722462-79725029:- | ESCA | EER | Macrophages_M2 | 4.2332e-02 | -0.2367 |  |
| ENSG00000225484.5,NUTM2B-AS1 | ESCA | EAG | T_cells_CD8 | 1.7451e-02 | 0.2263 |  |
| ENSG00000225484.5,NUTM2B-AS1 | KIRC | EAG | Dendritic_cells_activated | 8.5128e-03 | 0.3288 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LGG | EAG | NK_cells_activated | 2.0292e-03 | 0.2534 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LUAD | EAG | T_cells_CD8 | 2.0245e-02 | 0.2530 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LUSC | EAG | Dendritic_cells_resting | 3.1503e-02 | -0.3406 |  |
| chr10:79718939-79719186:- | OV | EER | T_cells_CD8 | 1.2308e-02 | 0.3354 |  |
| ENSG00000225484.5,NUTM2B-AS1 | OV | EAG | T_cells_CD8 | 2.8364e-03 | 0.2437 |  |
| ENSG00000225484.5,NUTM2B-AS1 | PCPG | EAG | NK_cells_resting | 1.4235e-03 | 0.5400 |  |
| ENSG00000225484.5,NUTM2B-AS1 | PRAD | EAG | Dendritic_cells_activated | 2.9962e-02 | 0.3394 |  |
| chr10:79722462-79725029:- | STAD | EER | T_cells_CD4_naive | 2.0692e-03 | 0.3155 |  |
| ENSG00000225484.5,NUTM2B-AS1 | STAD | EAG | NK_cells_activated | 2.1256e-03 | 0.2139 |  |
| ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
| chr10:79722462-79725029:- | BRCA | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 3.0229e-03 | 0.3043 |  |
| ENSG00000225484.5,NUTM2B-AS1 | BRCA | GSVA_HALLMARK_MITOTIC_SPINDLE | EAG | 2.3363e-04 | 0.2340 |  |
| ENSG00000225484.5,NUTM2B-AS1 | CESC | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EAG | 2.3010e-02 | 0.3680 |  |
| chr10:79718939-79719186:- | ESCA | GSVA_HALLMARK_APICAL_JUNCTION | EER | 1.1639e-03 | 0.3856 |  |
| ENSG00000225484.5,NUTM2B-AS1 | ESCA | GSVA_HALLMARK_KRAS_SIGNALING_DN | EAG | 3.8235e-03 | 0.2736 |  |
| chr10:79722462-79725029:- | ESCA | GSVA_HALLMARK_APICAL_SURFACE | EER | 6.9565e-03 | 0.3112 |  |
| ENSG00000225484.5,NUTM2B-AS1 | HNSC | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 2.0563e-02 | -0.3744 |  |
| ENSG00000225484.5,NUTM2B-AS1 | KIRC | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EAG | 2.0673e-02 | 0.2910 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LAML | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EAG | 5.0789e-03 | -0.3066 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LGG | GSVA_HALLMARK_G2M_CHECKPOINT | EAG | 3.3018e-03 | -0.2416 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LUAD | GSVA_HALLMARK_PEROXISOME | EAG | 2.2674e-03 | 0.3287 |  |
| chr10:79718939-79719186:- | OV | GSVA_HALLMARK_COMPLEMENT | EER | 1.9642e-04 | 0.4817 |  |
| ENSG00000225484.5,NUTM2B-AS1 | OV | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EAG | 3.6797e-03 | -0.2373 |  |
| ENSG00000225484.5,NUTM2B-AS1 | PCPG | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 3.1852e-02 | 0.3802 |  |
| ENSG00000225484.5,NUTM2B-AS1 | PRAD | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EAG | 3.7060e-03 | -0.4432 |  |
| ENSG00000225484.5,NUTM2B-AS1 | STAD | GSVA_HALLMARK_TGF_BETA_SIGNALING | EAG | 4.7689e-03 | -0.1969 |  |
| chr10:79731926-79732970:- | STAD | GSVA_HALLMARK_BILE_ACID_METABOLISM | EER | 1.9960e-03 | 0.3944 |  |
| chr10:79722462-79725029:- | STAD | GSVA_HALLMARK_ALLOGRAFT_REJECTION | EER | 4.8133e-03 | 0.2900 |  |
| chr10:79718939-79719186:- | STAD | GSVA_HALLMARK_ANDROGEN_RESPONSE | EER | 4.5956e-02 | -0.2098 |  |
| ENSG00000225484.5,NUTM2B-AS1 | THCA | GSVA_HALLMARK_FATTY_ACID_METABOLISM | EAG | 3.2266e-02 | -0.3680 |  |
| ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
| chr10:79722462-79725029:- | BRCA | LFM.A13 | EER | 2.2205e-02 | 0.2370 |  |
| chr10:79718939-79719186:- | BRCA | Embelin | EER | 4.3349e-03 | -0.2237 |  |
| ENSG00000225484.5,NUTM2B-AS1 | BRCA | FH535 | EAG | 4.5550e-02 | -0.1284 |  |
| ENSG00000225484.5,NUTM2B-AS1 | CESC | Dasatinib | EAG | 2.2922e-04 | -0.5702 |  |
| ENSG00000225484.5,NUTM2B-AS1 | COAD | Gemcitabine | EAG | 3.6708e-02 | 0.4038 |  |
| chr10:79718939-79719186:- | ESCA | Bexarotene | EER | 1.1762e-02 | -0.3039 |  |
| ENSG00000225484.5,NUTM2B-AS1 | ESCA | CCT018159 | EAG | 9.7591e-04 | -0.3115 |  |
| chr10:79722462-79725029:- | ESCA | FTI.277 | EER | 6.4313e-04 | -0.3877 |  |
| ENSG00000225484.5,NUTM2B-AS1 | HNSC | AZD8055 | EAG | 2.0614e-04 | 0.5670 |  |
| ENSG00000225484.5,NUTM2B-AS1 | KIRC | BI.D1870 | EAG | 3.0971e-04 | 0.4398 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LAML | CGP.082996 | EAG | 1.2326e-02 | 0.2752 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LGG | Embelin | EAG | 2.6274e-04 | 0.2977 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LUAD | FH535 | EAG | 4.1210e-05 | -0.4318 |  |
| ENSG00000225484.5,NUTM2B-AS1 | LUSC | CHIR.99021 | EAG | 2.6785e-03 | 0.4622 |  |
| chr10:79718939-79719186:- | OV | BMS.708163 | EER | 9.8258e-03 | -0.3453 |  |
| ENSG00000225484.5,NUTM2B-AS1 | OV | CI.1040 | EAG | 4.9680e-04 | -0.2828 |  |
| ENSG00000225484.5,NUTM2B-AS1 | PCPG | Bleomycin | EAG | 1.7729e-02 | 0.4165 |  |
| ENSG00000225484.5,NUTM2B-AS1 | PRAD | GW.441756 | EAG | 5.5078e-03 | 0.4258 |  |
| chr10:79718939-79719186:- | SKCM | Cytarabine | EER | 9.5019e-03 | -0.5287 |  |
| ENSG00000225484.5,NUTM2B-AS1 | SKCM | Cytarabine | EAG | 2.1234e-03 | -0.5158 |  |
| ENSG00000225484.5,NUTM2B-AS1 | STAD | EHT.1864 | EAG | 1.4587e-02 | -0.1708 |  |
| chr10:79722462-79725029:- | STAD | GW.441756 | EER | 2.7069e-03 | 0.3076 |  |